Donate

News

 

EDUCATION SESSIONS – WEBINARS

TWO upcoming webinars on Monday 11 May

You are invited to join us on Monday 11 May 2020 for two presentations on novel (new) therapies.
Both sessions are for current and former patients, carers, friends and health professionals.
These are FREE events to attend.

You will need to register separately for each session as each one has a different meeting ID and link.

1. Novel Therapies in Indolent Lymphomas

This
education session focuses on novel therapies for indolent lymphomas and
an update from Lymphoma Australia on our services and supports.

Time: 12.15pm – 1.30pm

Presenter: Dr Michael Gilbertson,
Monash Health

Topics include:

  • Novel (new) therapy in indolent (slow-growing) lymphoma
  • Lymphoma Australia services and supports available
  • Live Q&A – have your questions answered

MORE INFORMATION & REGISTRATION

 

2. Aggressive Lymphomas & CAR T-cell Therapy

This education session focuses on novel therapies for aggressive lymphomas and an update on CAR T-cell therapy.

Time: 2.00-5.30pm

Presenters:

  • Dr Michael
    Dickinson, Peter MacCallum Cancer Centre
  • Victorian Cancer Council
  • Deborah Sims, Lymphoma patient & advocate

Topics include:

  • Novel (new) therapies in aggressive (fast growing) lymphoma
  • CAR T-cell therapy
  • Emotional impact of cancer
  • Deborah Sims – a patient experience
  • Live Q&A chat

MORE INFORMATION & REGISTRATION

Sign up to our Newsletter

Back to top
Sign Up
About Us
Lymphoma
Patients
Get Involved
Lymphoma Australia is the only incorporated charity in Australia dedicated to solely providing education, support, awareness and advocacy initiatives for Australians touched by lymphoma and chronic lymphocytic leukemia (CLL).
Copyright © 2025. Lymphoma Australia
Linkedin Spotify
Contact Us
Share This
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.